Monthly Archives: March 2014

Top Las Vegas Pain Management Clinic, Nevada Pain, Now Offering Stem Cell Therapy to Help Avoid Joint Replacement

Posted: March 12, 2014 at 7:46 pm

Las Vegas, Nevada (PRWEB) March 12, 2014

The top Las Vegas pain management centers, Nevada Pain, are now offering regenerative medicine treatments including stem cell therapy and platelet rich plasma therapy. These treatments offer significant potential for repairing injured soft tissues and arthritis. Call (702) 323-0553 for more information and scheduling.

Traditional pain management treatments typically work exceptionally well, however, they act as a proverbial "band aid" to mask pain. Regenerative medicine, on the other hand, may regenerate damaged tissue while providing exceptional pain relief.

Treatments are offered by the Board Certified, Award Winning Las Vegas pain management doctors at Nevada Pain. Platelet rich plasma therapy is one of the treatments offered, which involves a simple blood draw from the patient. The blood is spun rapidly to create a mixture of concentrated platelets and growth factors, which is then injected into the problem area.

Stem cell injections involve treatments with either bone marrow, fat derived or amniotic derived material. The injections are offered as an outpatient and involve very little risk. Each treatment provides a significant concentration of growth factors and stem cells to help with repair.

In addition to regenerative medicine options, Nevada Pain offers over 50 pain management treatments including radiofrequency ablation, spinal cord stimulator implants, several types of epidural injections, and all kinds of nerve blocks. Success rates at the clinic typically exceed 90%.

For more information and scheduling, call (702) 323-0553.

Original post:
Top Las Vegas Pain Management Clinic, Nevada Pain, Now Offering Stem Cell Therapy to Help Avoid Joint Replacement

Posted in Stem Cell Therapy | Comments Off on Top Las Vegas Pain Management Clinic, Nevada Pain, Now Offering Stem Cell Therapy to Help Avoid Joint Replacement

Hutchins Society: 'Renal Failure & Stem Cells' – Video

Posted: March 12, 2014 at 12:54 pm


Hutchins Society: #39;Renal Failure Stem Cells #39;
Courtesy of WCGS Photographers #39; Society *******************************************************

By: WCGS Photographers #39; Society

The rest is here:
Hutchins Society: 'Renal Failure & Stem Cells' - Video

Posted in Stem Cells | Comments Off on Hutchins Society: 'Renal Failure & Stem Cells' – Video

Stem Cell | Skeletal muscle source of stem cells – Video

Posted: March 12, 2014 at 12:54 pm


Stem Cell | Skeletal muscle source of stem cells
Skeletal muscle stem cells... another alternative? Matsumoto and colleagues, in an article published in Arthritis and Rheumatism, looked at a rat model of os...

By: Nathan Wei

Originally posted here:
Stem Cell | Skeletal muscle source of stem cells - Video

Posted in Stem Cells | Comments Off on Stem Cell | Skeletal muscle source of stem cells – Video

Scientist who created STAP stem cells says studies should be withdrawn

Posted: March 12, 2014 at 12:54 pm

A number of scientists have been grumbling for weeks about a pair of breakthrough stem cell studies that seemed too good to be true. Now one of the senior researchers who worked on the papers agrees that they may be right.

The studies, which were published in January by the journal Nature, described a surprisingly simple method of transforming mature cells into pluripotent stem cells capable of regenerating any type of tissue in the body. The key was to stress them out by soaking them in an acid bath for 30 minutes, prompting genetic changes that made the cells more flexible. The researchers dubbed their technique stimulus triggered acquisition of pluripotency, or STAP.

But Teruhiko Wakayama, a senior author of one of the papers and coauthor on the other, said he had lost confidence in the studies and was "no longer sure the STAP cells were actually created, according to NHK.

Wakayama, a professor at the University of Yamanashi in Kofu, Japan, told Japanese media Monday that he had asked his collaborators to withdraw the studies until the results could be verified by independent scientists. He added that he is ready to provide cell samples and detailed data to anyone who is willing to try, NHK reported.

RELATED: New method makes stem cells in about 30 minutes, scientists report

Wakayama also echoed concerns raised by others that some of the images used in the Nature papers may have been published previously. According to Japan News, an English-language website from Yomiuri Shimbun, Wakayama said the images look almost identical to images that appear in the PhD thesis of Haruko Obokata, the lead author of both Nature studies. Her thesis was about pluripotent stem cells in humans, but the cells in the Nature STAP paper were supposedly from mice.

Anonymous posters to a website called PubPeer have flagged several images in the Nature papers that they say look suspiciously like pictures in a 2011 study led by Obokata. That study, published in the journal Tissue Engineering, purports to show that cells removed from various tissues of adult mice could be coaxed to grow into other kinds of cells.

Duplicated images arent the only problem skeptics have flagged. A Japanese blog post has noted striking similarities in the words used to describe some of the methods used in one of the Nature papers and the words in a 2005 paper published in a journal called In Vitro Cellular & Developmental Biology Animal. In the blog post, the overlapping language is highlighted in red.

There sure seems to be a lot of overlap in text in the two papers, Paul Knoepfler, a stem cell researcher at UC Davis, wrote on his blog.

Ive heard people react to this by saying 'no big deal, its just a methods section,' while Ive heard others say 'this is misconduct,' Knoepfler added. Im sure many people fall somewhere in the middle.

More here:
Scientist who created STAP stem cells says studies should be withdrawn

Posted in Stem Cells | Comments Off on Scientist who created STAP stem cells says studies should be withdrawn

Japanese stem cell scientist calls for retraction of study

Posted: March 12, 2014 at 12:54 pm

TOKYO: A co-author of a Japanese study that promised a revolutionary way to create stem cells has called for the headline-grabbing research to be retracted over claims its data was faulty.

The findings, published by Japanese researcher Haruko Obokata and US-based scientists, outlined a simple and low-tech approach in the quest to grow transplant tissue in the lab.

The study was touted as the third great advance in stem cells -- a futuristic field that aims to reverse Alzheimer's, cancer and other crippling or lethal diseases.

But it faced hard questions as the Japan-based Riken institute, which sponsored the study, launched a probe last month over the credibility of data used in the explosive findings.

At issue are allegations that researchers used erroneous image data for an article published in the January edition of British journal Nature.

Teruhiko Wakayama, a Yamanashi University professor who co-authored the article, called for a retraction.

"It's hard to believe the findings anymore after so many mistakes in the data," he told broadcaster Nippon Television late Monday.

On Tuesday, the institute said it was mulling whether to pull back the study.

"We are considering whether to retract the report based on its credibility and research ethics, even though our investigation is still underway," it said.

In an e-mailed statement, the journal said: "Issues relating to this paper have been brought to Nature's attention and we are conducting an ongoing investigation. We have no further comment at this stage."

Read this article:
Japanese stem cell scientist calls for retraction of study

Posted in Stem Cells | Comments Off on Japanese stem cell scientist calls for retraction of study

Japan stem cell scientist calls for retraction of study

Posted: March 12, 2014 at 12:54 pm

TOKYO: A co-author of a Japanese study that promised a revolutionary way to create stem cells has called for the headline-grabbing research to be retracted over claims its data was faulty.

The findings, published by Japanese researcher Haruko Obokata and US-based scientists, outlined a simple and low-tech approach in the quest to grow transplant tissue in the lab.

The study was touted as the third great advance in stem cells a futuristic field that aims to reverse Alzheimers, cancer and other crippling or lethal diseases.

But it faced hard questions as the Japan-based Riken institute, which sponsored the study, launched a probe last month over the credibility of data used in the explosive findings.

At issue are allegations that researchers used erroneous image data for an article published in the January edition of British journal Nature.

Teruhiko Wakayama, a Yamanashi University professor who co-authored the article, called for a retraction.

Its hard to believe the findings anymore after so many mistakes in the data, he told broadcaster Nippon Television late Monday.

On Tuesday, the institute said it was mulling whether to pull back the study.

We are considering whether to retract the report based on its credibility and research ethics, even though our investigation is still underway, it said.

In an e-mailed statement, the journal said: Issues relating to this paper have been brought to Natures attention and we are conducting an ongoing investigation. We have no further comment at this stage.

Continue reading here:
Japan stem cell scientist calls for retraction of study

Posted in Stem Cells | Comments Off on Japan stem cell scientist calls for retraction of study

Free online software helps speed up genetic discoveries

Posted: March 12, 2014 at 12:50 pm

Microarray analysis -- a complex technology commonly used in many applications such as discovering genes, disease diagnosis, drug development and toxicological research -- has just become easier and more user-friendly. A new advanced software program called Eureka-DMA provides a cost-free, graphical interface that allows bioinformaticians and bench-biologists alike to initiate analyses, and to investigate the data produced by microarrays. The program was developed by Ph.D. student Sagi Abelson of the Rappaport Faculty of Medicine at the Technion-Israel Institute of Technology in Haifa, Israel.

DNA microarray analysis, a high-speed method by which the expression of thousands of genes can be analyzed simultaneously, was invented in the late 1980s and developed in the 1990s. Genetic researchers used a glass slide with tiny dots of copies of DNA to test match genes they were trying to identify. Because the array of dots was so small, it was called a "microarray." There is a strong correlation between the field of molecular biology and medical research, and microarray technology is used routinely in the area of cancer research and other epidemiology studies. Many research groups apply it to detect genetic variations between biological samples and information about aberrant gene expression levels can be used in what is called "personalized medicine." This includes customized approaches to medical care, including finding new drugs for gene targets where diseases have genetic causes and potential cures are based on an individual's aberrant gene's signal.

An article written by Abelson published in the current issue of BMC Bioinformatics (2014,15:53) describes the new software tool and provides examples of its uses.

"Eureka-DMA combines simplicity of operation and ease of data management with the rapid execution of multiple task analyses," says Abelson. "This ability can help researchers who have less experience in bioinformatics to transform the high throughput data they generate into meaningful and understandable information."

Eureka-DMA has a distinct advantage over other software programs that only work "behind the scenes" and provide only a final output. It provides users with an understanding of how their actions influence the outcome throughout all the data elucidation steps, keeping them connected to the data, and enabling them to reach optimal conclusions.

"It is very gratifying to see the insightful initiative of Sagi Abelson, a leading 'out-of-the-box' thoughtful Technion doctorate student whom I have had the privilege of supervising," said Prof. Karl Skorecki, the Director of the Rappaport Family Institute for Research in the Medical Sciences at the Technion Faculty of Medicine and Director of Medical and Research Development at the Rambam Health Care Campus. "Over and above his outstanding PhD thesis research project on cancer stem cells, Sagi has developed -- on his own -- a user-friendly computer-based graphical interface for health and biological research studies. Eureka-DMA enables users to easily interpret massive DNA expression data outputs, empowering researchers (and in the future, clinicians) to generate new testable hypotheses with great intuitive ease, and to examine complex genetic expression signatures of genes that provide information relevant to health and disease conditions. This was enabled by combining outstanding insight and expertise in biological and computer sciences, demonstrating the unique multidisciplinary strengths and intellectual freedom that fosters creative innovation at the Technion."

According to Abelson, Eureka-DMA was programmed in MATLAB, a high-level language and interactive environment for numerical computation, visualization, and programming. Advanced users of MATLAB can analyze data, develop algorithms, and create models and applications to explore multiple hypotheses and reach solutions faster than with spreadsheets or traditional software. Eureka-DMA uses many of MATLAB's toolbox features to provide ways to search for enriched pathways and genetic terms and then combines them with other relevant features.

Raw data input is through Windows Excel or text files. This, says Abelson, spares the user from dealing with multiple and less common microarray files received by different manufacturers. Results can then be exported into a 'txt' file format,' or Windows Excel, making Eureka-DMA a unified and flexible platform for microarray data analysis, interpretation and visualization. It can also be used as a fast validation tool for results obtained by different methods.

Eureka-DMA loads and exports genetic data, "normalizes" raw data, filters non-relevant data, and enables pathway enrichment analysis for mapping genes on cellular pathways. The user can browse through the enriched pathways and create an illustration of the pathway with the differentially expressed genes highlighted.

After identifying the differentially expressed genes, biological meaning is ascribed via the software so that the identification of significant co-clustered genes with similar properties -- cellular components, a biological process, or a molecular function -- can be achieved.

See original here:
Free online software helps speed up genetic discoveries

Posted in Genetic medicine | Comments Off on Free online software helps speed up genetic discoveries

DaSilva Institute of Anti-Aging, Regenerative & Functional Medicine Offers Autologous Stem Cell Therapy for Men …

Posted: March 12, 2014 at 12:45 pm

Sarasota, FL (PRWEB) March 12, 2014

Erectile dysfunction (ED) is the most commonly studied disorder when it comes to male sexual dysfunction. It is estimated that 18 million men in the US alone suffer from erectile dysfunction and that it appears to be affecting 1 in 4 males under age 40 according to a study published in The Journal of Sexual Medicine.

While the emphasis of treatments for ED focuses on relieving the symptoms, they only provide a temporary solution rather than a cure or reversing the cause.

The DaSilva Institute is excited to announce the recruitment of males suffering from ED, in an IRB study, which will look at the safety, and efficacy of autologous, adipose derived stem cells (ADSCs) in regenerating the causes of ED.

The evidence shows that ADSCs reverses the pathophysiological changes leading to ED, rather than treating the symptoms of ED. Not only is the data in the literature compelling, but our own, in-house, results on our patients have been phenomenal, states Dr. DaSilva.

The many underlying causes for ED that are being investigated range from those secondary to aging, to injury of the cavernous nerve secondary to injury, surgery and/or radiation of the prostate, to diabetic ED and Peyronies Disease to name a few. According to Dr. DaSilva, the possibilities for ADSCs in reversing ED are limitless.

Currently, there is an expansive and growing body of evidence in the medical literature strongly indicating that ADSCs might be a potential cure for ED, rather than merely symptom relief, which is indicative of the increasing interest in ADSC-regenerative options for sexual medicine over the past decade. The DaSilva Institutes goal is to take this from pre-clinical studies to the clinical world offering it to all males that suffer from intractable ED under an IRB approved protocol.

More information about Dr. DaSilva and the DaSilva Institute Guy DaSilva, MD is currently the medical director of the DaSilva Institute of Anti-Aging, Regenerative & Functional Medicine, located in Sarasota, Florida. Dr. DaSilvas enthusiasm for using autologous stem cells in regenerative medicine comes from his early days as a pathologist in New York City back in 1987 and later as a fellow in hematology in1990 following his residency in internal medicine.

He later brought his expertise in molecular and cellular medicine to the University of Kansas Medical Center where he served as chief of Hematology & Hematopathology. He later became the CEO and medical director of HemePath Institute, a diagnostic leader in diagnosing the most difficult cases of leukemia and lymphomas. Most recently, Dr. DaSilva teamed up with one of the most influential stem cell scientist in the world to bring the highest quality and viability of the harvested stem cells, bar none, to the DaSilva Institute.

Dr. DaSilva is board certified and fellowship trained in Anti-Aging and Regenerative Medicine. For more information about Dr. DaSilva or the DaSilva Institute go to http://www.dasilvainstitute.com.

Continue reading here:
DaSilva Institute of Anti-Aging, Regenerative & Functional Medicine Offers Autologous Stem Cell Therapy for Men ...

Posted in Cell Medicine | Comments Off on DaSilva Institute of Anti-Aging, Regenerative & Functional Medicine Offers Autologous Stem Cell Therapy for Men …

Advances in Stem Cell, Organ Printing, Tissue Engineering Changing Healthcare, Saving Lives

Posted: March 12, 2014 at 12:45 pm

Contact Information

Available for logged-in reporters only

Newswise COLUMBUS, Ohio -- Imagine a world where malfunctioning organs are replaced by new ones made from your own tissues, where infected wounds are cured with a signal from your smartphone, where doctors find the perfect medicine for whatever ails you simply by studying your stem cells.

Its a world thats inching closer to reality because of the work of some of the nations top scientists, many of whom will gather March 13-15 at The Ohio State University for the 7th Annual Translational to Clinical (T2C) Regenerative Medicine Conference to discuss their recent successes and challenges in coaxing the body to heal itself in extraordinary ways.

Regenerative medicine will change the way you and I experience sickness, health and healthcare, said Chandan Sen, director of the Center for Regenerative Medicine and Cell Based Therapies at Ohio States Wexner Medical Center. Because the field is so new, we as researchers are also changing the way we work to be synergistic not competitive, so patients are able to access the benefits more quickly.

And the benefits are desperately needed, says keynote speaker Dr. Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine at Wake Forest Baptist Medical Center.

From chronic diseases such as kidney failure that costs billions of dollars each year to the medical needs of our aging population and the significant injuries sustained by military troops in Afghanistan, developing new treatment paradigms is essential, said Atala, who was selected to lead the $75 million Armed Forces Institute of Regenerative Medicine (AFIRM), a consortium of 30 academic and industry partners in applying regenerative medicine techniques to battlefield injuries.

In theory, every tissue in the body has the ability to regenerate and heal itself. Its good to come to this meeting and exchange ideas that will enable us to harness that remarkable ability.

Other speakers include Elaine Fuchs, Howard Hughes Medical Institute investigator and Rebecca C. Lancefield Professor at Rockefeller University in New York, who has advanced multiple areas of stem cell research through her work in skin cells and genetics; and Dr. Michael Longaker, director of the Hagey Laboratory for Stem Cell Biology for Pediatric Regenerative Medicine at Stanford University. Longaker is considered one of the nations experts in using a combination of stem cell- and bioengineering-based technologies for craniofacial reconstruction.

Several Ohio State College of Medicine and Wexner Medical Center clinician-scientists are also sharing research updates during pre-conference lectures and the meeting:

See the rest here:
Advances in Stem Cell, Organ Printing, Tissue Engineering Changing Healthcare, Saving Lives

Posted in Cell Medicine | Comments Off on Advances in Stem Cell, Organ Printing, Tissue Engineering Changing Healthcare, Saving Lives

Miami Stem Cell Treatment Center: What The Stem Cell Procedure Entails and An Invitation To MSCTC Public Seminar; Meet …

Posted: March 12, 2014 at 12:43 pm

Boca Raton, Florida (PRWEB) March 12, 2014

The Miami Stem Cell Treatment Center, PC, located in Miami, Ft. Lauderdale, and Boca Raton, Florida, offers a free public seminar on the use of stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief, and, Dr. Nia Smyrniotis, Medical Director. The next upcoming seminar will be held on March 16th at the Comfort Suites Weston, 2201 N. Commerce Parkway, Weston, Florida 33326, at 2pm.

Regenerative Medicine: Our Procedure The Miami Stem Cell Treatment Center uses Autologous Adult Adipose Stem Cells to provide care for patients suffering from chronic conditions that may benefit from adult stem cell-based regenerative medicine.

The Miami Stem Cell Treatment Center follows the regenerative medicine procedures developed by the California Stem Cell Treatment Centers (CSCTC) and Cell Surgical Network (CSN) which involves the initial screening, examination and evaluation of every potential candidate for stem cell investigational therapy by one of our physicians. Once a patient is deemed to be an appropriate candidate, the procedure itself is performed by our Surgeon-in-Chief, who is assisted by a team of experienced surgical team members and surgical technicians. The entire process from start to finish takes less than two hours. It is relatively painless, and recovery time is minimal.

In recent times, the bone marrow has been a source for stem cells. Taking bone marrow, however, is a painful procedure. Fat, however, contains many times more stem cells than bone marrow and is much easier and safer to harvest.

For many disease types such as cardiac pathology, adipose derived cells appear to be showing superiority to bone marrow derived cells. This may be related to the well documented fact that chronic disease causes bone marrow suppression. Fat derived cells are a natural choice for our investigational work considering their easy and rapid availability in extremely high numbers.

With our current technology, we can harvest your own fat cells, digest the fat cells and separate out the stem cells. The most significant advantage of using your fat as a source for the stem cells, is that the procedure can be done in the office in only a few hours, as the stem cells can be ready for injection after only 60 minutes of processing with our state of the art equipment. Your stem cells do NOT need to be sent out for processing and there is no need for you to travel outside of the U.S. to have them injected.

Indeed, adipose tissue is an abundant source of mesenchymal stem cells, which have shown promise in the field of regenerative medicine. Furthermore, these cells can be readily harvested in large numbers with low donor-site morbidity. During the past decade, numerous studies have provided pre-clinical data on the safety and efficacy of adipose-derived stem cells, supporting the use of these cells in clinical applications. Various clinical trials have shown the regenerative capability of adipose-derived stem cells in numerous fields of medicine. In addition, a great deal of knowledge concerning the harvesting, characterization, and culture of adipose-derived stem cells has been reported.

Our current areas of study include: Heart Failure, Emphysema, COPD, Asthma, Parkinsons Disease, Stroke, Multiple Sclerosis, and orthopedic joint injections. . The investigational protocols utilized by the Miami Stem Cell Treatment Center have been reviewed and approved by an IRB (Institutional Review Board) which is registered with the U.S. Department of Research Protections; and the study is registered with http://www.Clinicaltrials.gov, a service of the U.S. National Institutes of Health (NIH). For more information contact: Miami(at)MiamiStemCellsUSA(dot)com or visit our website: http://www.MiamiStemCellsUSA.com.

See the article here:
Miami Stem Cell Treatment Center: What The Stem Cell Procedure Entails and An Invitation To MSCTC Public Seminar; Meet ...

Posted in Cell Therapy | Comments Off on Miami Stem Cell Treatment Center: What The Stem Cell Procedure Entails and An Invitation To MSCTC Public Seminar; Meet …